BHA536

BHA536 is an orally bioavailable small molecule that inhibits PKCα/β and NF-κB signaling. It suppresses proliferation and induces apoptosis in CD79-mutant ABC DLBCL cell lines like TMD8, and demonstrates in vivo antitumor efficacy in mouse models, supporting its use in oncology research.